Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
about
ESUR prostate MR guidelines 2012Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessmentPET/MRI in Oncological Imaging: State of the ArtRole of multiparametric magnetic resonance imaging in early detection of prostate cancerThe current and future role of magnetic resonance imaging in prostate cancer detection and managementThe role of magnetic resonance imaging in the diagnosis and management of prostate cancerThe role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelFunctional MRI in prostate cancer detectionTargeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancerMultiparametric-MRI in diagnosis of prostate cancerIncremental value of magnetic resonance imaging in the advanced management of prostate cancer.Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessmentIs apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRSMagnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancerAdvances in prostate cancer imaging techniques and strategies.Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.Anatomic imaging of the prostate.In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS V.2 based score.Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy.Multiparametric MRI in the Detection of Clinically Significant Prostate CancerDetection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequenceHaralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRI.Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer.A systematic review on multiparametric MR imaging in prostate cancer detection.Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard.Rapid quantitative T2 mapping of the prostate using three-dimensional dual echo steady state MRI at 3T.
P2860
Q24620926-4D62112A-9E33-4CC8-A718-DD245A1C597EQ26749212-D5BE964C-6E77-48B2-BF23-90FA17889F5FQ26768474-D75C1421-48C1-4643-9B83-55777EBFC4AEQ26768765-CC72CCCF-E270-43E4-AC86-DDF85B57F580Q26773645-3B708EB2-21D9-4093-ACC4-15F0083C5207Q26849794-20B0D005-1AAB-4C13-823A-33EBA88C278AQ27006744-07DABE94-F428-463E-AB7B-E9B0332D738EQ27009471-A68DD273-6556-4D1F-90B9-9670775272A6Q27027567-FAF5A911-853A-4E3F-96A6-2F8CCB3AC849Q28081873-4EAE2416-48C0-43CE-9AE9-219A5872975EQ33772524-9C391F0B-AB08-4C6C-8994-8A340B55C48CQ34475350-7015AC4D-1794-41A5-AD10-3A5C09BDA530Q34534796-9A6732B8-DD7F-4398-AE09-9247DB799C91Q34893798-109567E6-97F8-44FB-B034-9EF08FE59DB4Q35354750-BA1A6F77-845F-401F-92D4-E61C8902AAE5Q35600604-1A69DFF2-8255-4385-89F0-064E4D9A2C4AQ36793589-3A3C11E7-8C6B-43DE-B102-817983EBDCAFQ36795496-F08CDBD5-CF55-4C4D-A9D6-D6A8622ACDE3Q37003074-31B4C125-7369-4211-97D1-C3F3E0592577Q37018444-4DD7A21B-C14A-497E-8E87-CDF8491B43B2Q37127345-B0EA3B40-E2BD-48CB-8587-08148E7C6CB1Q37823843-ECAEBE33-DC89-418A-9079-315474C317CCQ37878465-0EDB8ED5-F5B6-4E75-98A8-1611991ED013Q37968978-0AFAB2F4-2940-413B-A5FF-F80ABD263605Q38100740-F8DA80BE-4A23-4494-BB68-FF92E6EEDB31Q38190885-51F1F5D0-7279-4613-B94A-AF6EE0443FE7Q38253057-B1B89947-7D22-4876-864E-97F0700FC3A8Q39093014-27FDFADF-FAEE-4C38-88FD-F56D70E5CD86Q39282130-6AFC82F0-D6D2-4101-BE18-FC62446FA44DQ39410146-F62E47F0-E521-43C7-9411-35EB947EA004Q39601617-5A107C74-4486-4206-BD07-F077353FC651Q40243618-22AF598F-04CB-4FB2-A7E3-3CD1A5226CE7Q40498085-FF71AA67-80EA-4ED9-AEA8-B7FD1333BD60Q41110614-D150F3D8-D82E-46C9-BFC6-BC4F293DA69EQ41177087-319330B4-1517-485B-AD4B-E324684223E0Q42726465-94EEA9C8-410A-4E76-A386-1C592E9729D6Q43274222-4485E08B-CC53-4125-AB16-A81D29EA141EQ43529342-96BAF324-5F50-43ED-83A6-4E5213075B59Q46241732-A80653FB-BDC4-4C2E-AB73-6B06287AACB1Q46423474-77CFD31F-767C-40F8-BDD2-EA7C37588CBB
P2860
Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Assessment of biologic aggress ...... e after radical prostatectomy.
@en
Assessment of biologic aggress ...... e after radical prostatectomy.
@nl
type
label
Assessment of biologic aggress ...... e after radical prostatectomy.
@en
Assessment of biologic aggress ...... e after radical prostatectomy.
@nl
prefLabel
Assessment of biologic aggress ...... e after radical prostatectomy.
@en
Assessment of biologic aggress ...... e after radical prostatectomy.
@nl
P2093
P1433
P1476
Assessment of biologic aggress ...... e after radical prostatectomy.
@en
P2093
Jingbo Zhang
Kentaro Kuroiwa
Liang Wang
Nicole M Ishill
Yousef Mazaheri
P304
P356
10.1148/RADIOL.2461070057
P407
P577
2007-11-16T00:00:00Z